These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35801590)

  • 41. CCCTC-binding factor controls the homeostatic maintenance and migration of Langerhans cells.
    Kim TG; Kim M; Lee JJ; Kim SH; Je JH; Lee Y; Song MJ; Choi Y; Chung YW; Park CG; Cho JW; Lee MG; Lee YS; Kim HP
    J Allergy Clin Immunol; 2015 Sep; 136(3):713-24. PubMed ID: 25936568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Requirement of MyD88 signaling in keratinocytes for Langerhans cell migration and initiation of atopic dermatitis-like symptoms in mice.
    Didovic S; Opitz FV; Holzmann B; Förster I; Weighardt H
    Eur J Immunol; 2016 Apr; 46(4):981-92. PubMed ID: 26694221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions.
    Eidsmo L; Martini E
    Front Immunol; 2018; 9():300. PubMed ID: 29520279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy.
    Kim HR; Kim JC; Kang SY; Kim HO; Park CW; Chung BY
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
    Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Turnover and kinetics of epidermal Langerhans cells and their dendritic precursor cells in experimental contact dermatitis. A correlated ultrastructural-morphometric and immunohistochemical evaluation.
    Kolde G
    Arch Dermatol Res; 1996 Apr; 288(4):197-202. PubMed ID: 8967792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
    Morimura S; Oka T; Sugaya M; Sato S
    J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive Allosteric Modulation of A
    Welihinda A; Ravikumar P; Kaur M; Mechanic J; Yadav S; Kang GJ; Amento E
    J Invest Dermatol; 2022 Mar; 142(3 Pt A):624-632.e6. PubMed ID: 34536482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins.
    McGregor JM; Barker JN; Ross EL; MacDonald DM
    J Am Acad Dermatol; 1992 Sep; 27(3):383-8. PubMed ID: 1401271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways.
    Guo H; Li M; Liu H
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TIM-4 is differentially expressed in the distinct subsets of dendritic cells in skin and skin-draining lymph nodes and controls skin Langerhans cell homeostasis.
    Zhang X; Liu Q; Wang J; Li G; Weiland M; Yu FS; Mi QS; Gu J; Zhou L
    Oncotarget; 2016 Jun; 7(25):37498-37512. PubMed ID: 27224924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Langerhans cell: exciting developments in health and disease.
    Atmatzidis DH; Lambert WC; Lambert MW
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1817-1824. PubMed ID: 28833602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
    van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
    J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice.
    Shi YL; Gu J; Park JJ; Xu YP; Yu FS; Zhou L; Mi QS
    J Dermatol Sci; 2012 Nov; 68(2):99-107. PubMed ID: 22999682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of PUVA and mechlorethamine treatment of psoriatic patients on epidermal Langerhans' cells.
    Torinuki W; Mauduit G; Haftek M; Thivolet J
    Acta Derm Venereol; 1987; 67(6):532-5. PubMed ID: 2451383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
    Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
    Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
    Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
    J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resolvin E1 attenuates murine psoriatic dermatitis.
    Sawada Y; Honda T; Nakamizo S; Otsuka A; Ogawa N; Kobayashi Y; Nakamura M; Kabashima K
    Sci Rep; 2018 Aug; 8(1):11873. PubMed ID: 30089836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.